Mats focuses primarily on the technology sector in Europe. He is a German national and speaks German and English. His investment and board experience includes Lingoda, RadioOnkologieNetzwerk (acquired by Medipass) and Viroclinics Biosciences (acquired by Cerba Healthcare).
Prior to Summit, Mats worked in the Consumer Retail, Healthcare and Real Estate M&A Group at Goldman Sachs. Mats holds a BS, with first class honors, in accounting and finance from the London School of Economics.